AltPep

?? ANNOUNCING our new website launch! ? We’re excited to share our refreshed site, designed to highlight our science, our innovations, and our amazing team in action, working everyday with the goal to make a real difference for patients! ? Find out how AltPep is targeting early molecular triggers called alpha-sheet toxic oligomers, to change the course of amyloid diseases like Alzheimer’s and Parkinson’s disease, even before symptoms. Check it out! www.altpep.com #NewWebsite #CompanyNews #OurTeam #Alzheimers #Parkinsons

University of Washington just published a great article about the beginnings of AltPep, the support of CoMotion (UW’s innovation hub) and the progress AltPep is making.?It’s been an exciting journey! #alzheimersdisease #research #UW

We keep walking for a cure! Team AltPep completed another Walk to End Alzheimer's and we'd like to thank everyone who contributed on our behalf and all those who supported by attending the walk. #AlzheimersDisease #ENDALZ

Valerie Daggett, AltPep’s CEO was inducted into the Washington State Academy of Science this week.?This prestigious election recognizes members’ “outstanding record of scientific and technical achievement, and their willingness to work on behalf of the academy to bring the best available science to bear on issues within the state of Washington.” ? Congratulations?Valerie!

We're #hiring a new Research Associate - Peptide Production in Greater Seattle Area. Apply today or share this post with your network.

Earlier this week, our very own Jeff Posakony spoke at the Boulder Peptide Symposium, 2024 in Boulder, Colorado. His presentation was titled Synthetic Alpha-Sheet Peptides for Treatment of Amyloid Diseases; if you'd like to learn more about the symposium and the information shared there, please visit?https://lnkd.in/gXcki_cA

We're #hiring a new Senior Research Associate in Greater Seattle Area. Apply today or share this post with your network.

We're #hiring a new Research Associate, Diagnostics in Greater Seattle Area. Apply today or share this post with your network.

Seattle's Walk to End Alzheimer's is on September 28th!?AltPep has a team again this year, and we would love to have your support. Follow the link to find out how you can donate to the AltPep team or sign up to walk! ?https://lnkd.in/ggV_7Tme

We are excited to welcome Denis Sirringhaus to the AltPep team as Vice President of Business Development.?Denis most recently served as Executive Director of Business Development at Caribou Biosciences, where he helped secure a $25M Pfizer investment that led to a $134.6M follow-on offering. Prior to Caribou, Denis worked in Business Development at several biopharma companies, including Gossamer Bio and Genentech/Roche where he evaluated neuroscience assets including the in-license of Enspryng and the acquisition of Spark Therapeutics. He started his career at JPMorgan on the Specialty Pharma equity research team. Denis has an MBA from Wharton, a Master’s of Biotech from University of Pennsylvania and an AB in Biological Sciences from Harvard. Denis’ experience is ideally suited to help foster the partnerships needed for AltPep to realize its goal of transforming the treatment and detection of amyloid diseases, such as Alzheimer’s. Please join us in giving a warm welcome to Denis!